A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

Saved in:

Bibliographic Details
Published in:	Ann Oncol
Main Authors:	Dunn, L A, Fury, M G, Xiao, H, Baxi, S S, Sherman, E J, Korte, S, Pfister, C, Haque, S, Katabi, N, Ho, A L, Pfister, D G
Format:	Artigo
Language:	Inglês
Published:	Oxford University Press 2018
Subjects:	Corrigenda
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC6888018/ https://ncbi.nlm.nih.gov/pubmed/29300804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx801
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items